BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1982072)

  • 1. The role of autophosphorylation in modulation of erbB-2 transforming function.
    Segatto O; Lonardo F; Pierce JH; Bottaro DP; Di Fiore PP
    New Biol; 1990 Feb; 2(2):187-95. PubMed ID: 1982072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling.
    Segatto O; Lonardo F; Helin K; Wexler D; Fazioli F; Rhee SG; Di Fiore PP
    Oncogene; 1992 Jul; 7(7):1339-46. PubMed ID: 1352397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X
    Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic residues at the carboxyl terminus of p60c-src are required for regulation of tyrosine kinase activity and transformation.
    MacAuley A; Cooper JA
    New Biol; 1990 Sep; 2(9):828-40. PubMed ID: 1703788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of autophosphorylation sites of HER2/neu.
    Hazan R; Margolis B; Dombalagian M; Ullrich A; Zilberstein A; Schlessinger J
    Cell Growth Differ; 1990 Jan; 1(1):3-7. PubMed ID: 1706616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Cooper JA; Runge K
    Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.
    Akiyama T; Matsuda S; Namba Y; Saito T; Toyoshima K; Yamamoto T
    Mol Cell Biol; 1991 Feb; 11(2):833-42. PubMed ID: 1671296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites.
    Epstein RJ
    Oncogene; 1995 Jul; 11(2):315-23. PubMed ID: 7624146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
    Myers JN; LeVea CM; Smith JE; Kallen RG; Tung L; Greene MI
    Receptor; 1992; 2(1):1-16. PubMed ID: 1362129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.